Intellectual Property Rights and Access in Crisis

American Alliance of Museums (2020) National Survey of COVID-19 Impact on United States Museums, https://www.aam-us.org/2020/07/22/united-states-may-lose-one-third-of-all-museums-new-survey-shows/

Angelopoulos C (2012) The myth of European term harmonisation: 27 public domains for the 27 Member States, available at http://papers.ssrn.com/abstract=2145862

Aoki K (1998) Neocolonialism, anticommons property, and biopiracy in the (Not-so-Brave) New World Order. Indiana J Glob Legal Stud 6:11

Aoki R, Schiff A (2008) Promoting access to intellectual property: patent pools, copyright collectives, and clearinghouses. R&D Manag 38(2):189

Aritarathna L, Kariyawasam K (2020) Pharmaceutical patents and access to generic medicines in developing countries. EIPR 42(2):108

Bakels R, Hugenholtz B (2002) The patentability of computer programs. European Parliament, Legal Affairs Series

Barel A, Boman L (2020) Clinical trial cost transparency at the National Institutes of Health: law and policy recommendations. Engelberg Center on Innovation Law & Policy, available at https://www.law.nyu.edu/sites/default/files/Clinical_Trial_Cost_Transparency_at_the_NIH-Law_and_Policy_Recommendations.pdf

Bartow A (2006) Fair use and the fairer sex: gender, feminism, and copyright law. 14 American University Journal of Gender, Social Policy & the Law 551

Basheer S, Sanklecha J, Gowda P (2014) Pharmaceutical patent enforcement: a developmental perspective. In: Okediji R, Bagley M (eds) Patent law in a global perspective. Oxford University Press

Bertoni A (2012) Research and “development as freedom”—improving democracy and effectiveness in pharmaceutical innovation for neglected tropical diseases. IIC 43(7):771

Bor F (2006) Exemptions to patent infringement applied to biotechnology research rools. EIPR 28:510

Boseley S (2020) US secures world stock of key Covid-19 drug remdesivir’ The Guardian (London) available at https://www.theguardian.com/us-news/2020/jun/30/us-buys-up-world-stock-of-key-covid-19-drug

Boyle J (2008) The public domain: enclosing the commons of the mind. Yale University Press

Brauneis R, Oliar D (2018) An empirical study of the race, ethnicity, gand age of copyright registrants. George Washington Law Rev 86:101

Brown A, Ng C, Adebola T (2020) Intellectual property rights, the public interest and COVID-19 (University of Aberdeen, School of Law Blog) available at https://www.abdn.ac.uk/law/blog/intellectual-property-rights-the-public-interest-and-covid19/

Buccafusco C, Sprigman CJ (2019) Experiments in intellectual property. In: Mennel P, Schwartz D (eds) Research handbook on the economics of intellectual property law. Edward Elgar

Burkett I (2008) Beyond the “information rich and poor”: future understandings of inequality in globalising informational economies. Futures 32(7):679

COVID-19: Human development on course to decline this year for the first time since 1990 (2020) (United Nations Development Programme) https://www.undp.org/content/undp/en/home/news-centre/news/2020/COVID19_Human_development_on_course_to_decline_for_the_first_time_since_1990.html.

COVID-19 Open Access Letter (2020) https://wellcome.ac.uk/sites/default/files/covid19-open-access-letter.pdf

COVID-19 Special Issue (2020) 42(9) EIPR

Caddick N, Davies G, Harbottle G (2016) Copinger and Skone James on copyright (17th edn). Sweet & Maxwell

Callaway E (2020) The unequal scramble for coronavirus vaccines - by the numbers. Nature 584:506

Cameron C (2006) In defiance of Bridgeman: claiming copyright in photographic reproductions of public domain works. Texas Intell Property Law J 15:31

Chakchouk M, Giannini S (2020) Call for joint action: supporting learning and knowledge sharing through open educational resources (OER)’ available at https://en.unesco.org/sites/default/files/covid19_joint_oer_call_en.pdf

Chander A, Sunder M (2004) The romance of the public domain. California Law Rev 92:1331

Chesbrough H (2003) Open Innovation: the new imperative for creating and profiting from technology. Harvard University Press

Chesbrough H, Vanhaverbeke W, West J (eds) (2013) Open innovation: researching a new paradigm. Oxford University Press

Chon M (2006) Intellectual property and the development divide. Cardozo Law Rev 27:2821

Cole P, Davis R (2019) CIPA Guide to the Patents Acts, 9th edn. Sweet & Maxwell, London

Contreras J, Jacob M (eds) (2017) Patent pledges: global perspectives on patent law’s private ordering frontier. Edward Elgar

Contreras J, Eisen M, Ganz A, Lemley M, Molloy J, Peters D, Tietze F (2020a) Pledging intellectual property for COVID-19. Nat Biotechnol 38:1146

Contreras J, Eisen M, Peters D (2020b) COVID-19: save lives with open intellectual-property licences. Nature 583:683

Cook T (2006) A European perspective as to the extent to which experimental use, and certain other defences to patent infringement, apply to differing Types of Research: a report for the intellectual property institute. Intellectual Property Institute, London

Correa C (2000) Intellectual property rights, the WTO and developing countries: the TRIPS agreement and policy options. Zed Books

Craig C (2014) Feminist aesthetics and copyright law: genius, value, and gendered visions of the creative self. Osgoode Legal Studies Research Paper Series, available at https://digitalcommons.osgoode.yorku.ca/olsrps/31

Craig C (2007) Reconstructing the author-self: some feminist lessons for copyright law. Soc Policy 15:62

Craig C (2011) Copyright Communication and culture. Towards a relational theory of copyright law. Edward Elgar

Crews K (2012) Museum policies and art images: conflicting objectives and copyright overreaching’. 22 Fordham Intellectual Property, Media and Entertainment Law Journal 795

Crissinger S (2015) A critical take on OER practices: interrogating commercialization, colonialism, and content – in the library with the lead pipe, available at http://www.inthelibrarywiththeleadpipe.org/2015/a-critical-take-on-oer-practices-interrogating-commercialization-colonialism-and-content/

DG Connect (2016) Living labs and open innovation (Shaping Europe’s digital future - European Commission), available at https://ec.europa.eu/digital-single-market/en/news/living-labs-and-open-innovation

Domeij B (2000) Pharmaceutical patents in Europe. Stockholm Studies in Law, Kluwer Law International, The Hague

Drahos P, Braithwaite J (2002) Information feudalism: Who Owns the Knowledge Economy? Earthscan

Dryden J (2011) Copyfraud or legitimate concerns? Controlling further uses of online archival holdings’. Am Arch 74:522

Ebersole T, Guthrie M, Goldstein J (2005) Patent pools and standard setting in diagnostic genetics’. Nat Biotechnol 23(8):937

Fehrer P (2020) Pharma Companies are worried about pooling their IP. They shouldn’t be’ (Barron’s) available at https://www.barrons.com/articles/pharma-companies-are-worried-about-pooling-their-coronavirus-intellectual-property-they-shouldnt-be-51593178200

Fighting COVID-19 through digital innovation and transformation (2020) (UNESCO) https://en.unesco.org/covid19/communicationinformationresponse/digitalinnovation

Fisher W, Oberholzer-Gee F (2013) Strategic management of intellectual property: an Integrated Approach’. California Management Review 157

Fletcher ER, Hacker J, Hoecklin M (2020) Procure and supply vaccines through COVAX and not bilateral deals – WHO plea to countries and pharma’ (Health Policy Watch) https://healthpolicy-watch.news/fund-and-supply-vaccines-through-covax-and-not-bilateral-deals-pleads-who/

Frosio G (2012) Communia and the European Public Domain Project: a politics of the public domain. In: Dulong de Rosnay M, De Martin JC (eds), The digital public domain; foundations for an open culture. Open Book Publishers

Gana R (1996) The Myth of Development, The Progress of Rights: Human Rights to Intellectual Property and Development. Law Policy 18:315

Garrison C (2020) Never say never - Why the High Income Countries that opted-out from Art. 31bis WTO TRIPS system must urgently reconsider their decision in the face of the Covid-19 pandemic’ (Medicines Law & Policy) available at https://medicineslawandpolicy.org/2020/04/never-say-never-why-the-high-income-countries-that-opted-out-from-the-art-31bis-wto-trips-system-must-urgently-reconsider-their-decision-in-the-face-of-the-covid-19-pandemic/

Ginsburg J (1990) Creation and commercial value: copyright protection of works of information. Col L Rev 90:1865

Greenleaf G and Lindsay D (2018) Public rights: copyright’s public somains. Cambridge University Press

Gurry F (2020) Some Considerations on intellectual property, innovation, access and COVID-19’, available at https://www.wipo.int/about-wipo/en/dgo/news/2020/news_0025.html

Hadley W (2020) COVID-19 Impact: Museum Sector Research Findings Summary Report’ (Art Fund) available at https://www.artfund.org/assets/downloads/art-fund-covid19-research-report-final.pdf

Hawkins N, Garden H, Winickoff D (2021) Advancing Genomics and Biobanks for Personalised Medicine – building and sustaining collaborative platforms. OECD Science, Technology and Industry Working Papers 11 (in press)

Hill A et al (2020) Minimum costs to manufacture new treatments for COVID-19. J Virus Educ 6:61

Hope J (2008) Biobazaar: the open source revolution and biotechnology. Harvard University Press

Hudson E, Wragg P (2020) Proposals for copyright law and education during the COVID-19 pandemic’, available at https://ssrn.com/abstract=3617720

Iqbal Z, Iqbal Z, Sadaf S (2020) Impact of Bolar-exemption and compulsory licencing on market exclusivity and the public health crisis—perspective from developing countries. EIPR 42(6):364

Joint Letter to Dr Francis Gurry, Director General, World Intellectual Property Organization (2020) https://www.communia-association.org/wp-content/uploads/2020/04/200403-Joint-Letter-to-Dr-Francis-Gurry.pdf

Kapsalis E (2016) The impact of open access on galleries, libraries, museums, & archives (Smithsonian Institutes 2016) available at https://siarchives.si.edu/sites/default/files/pdfs/2016_03_10_OpenCollections_Public.pdf

Kaye J, Heeney C, Hawkins N, de Vries L, Boddington P (2009) Data sharing in genomics – re-shaping scientific practice. Nat Rev Genet 10:33

Kelly K (2013) Images of works of art in museum collections: the experience of open access. Council on Library and Information Resources

Lee N (2019) Intellectual Property Rights and open innovation in 3D printing: a different form of exclusivity. In: Drexl J, Kamperman Sanders A (eds), The Innovation Society and Intellectual Property. Edward Elgar

Lees N (2020) Covid-19 - Scientific Research on the Coronavirus Is Being Released in a Torrent’ (The Economist) available at https://www.economist.com/science-and-technology/2020/05/07/scientific-research-on-the-coronavirus-is-being-released-in-a-torrent

Leminen S, Westerlund M, Nyström A-G (2012) Living Labs as Open-Innovation Networks. Technology Innovation Management Review 6

Letter to ministers: Copyright and enabling remote learning and research during the COVID-19 crisis - UPDATED (2020) (RLUK Research Libraries UK) https://www.rluk.ac.uk/letter-to-ministers-copyright-and-enabling-remote-learning-and-research-during-the-covid-19-crisis/

Levine D (2020) COVID-19 Trade secrets and information access: an overview’ (Infojustice) available at http://infojustice.org/archives/42493

Li P, Lim PH (2014) A precautionary approach to compulsory licencing of medicines: tempering data exclusivity as an obstacle to access. IPQ 3:241

Light M (2015) Controlling goods or promoting the public good: choices for special collections in the marketplace. RBM A J Rare Books Manusc Cult Heritage 16:48

Love J (2020) Open letter asking 37 WTO members to declare themselves eligible to import medicines under compulsory licence in another country, under 31bis of TRIPS Agreement (KEI Online) https://www.keionline.org/32707

Manu T (2014) Essential medicines and the complexity of implementing nationally based compulsory licensing: on the need for a regional system of compulsory licensing in sub-Saharan Africa. EIPR 36(1):39

Mara K (2020) Decision on intellectual property waiver over Covid technology on hold till 2021 (Medicines Law & Policy) https://medicineslawandpolicy.org/2020/12/decision-on-intellectual-property-waiver-over-covid-technology-on-hold-till-2021-what-are-the-next-steps/

Matthews D (2020) Coronavirus: how countries aim to get the vaccine first by cutting opaque supply deals’ (The Conversation) available at https://theconversation.com/coronavirus-how-countries-aim-to-get-the-vaccine-first-by-cutting-opaque-supply-deals-143366

Mazzone J (2006) Copyfraud. New York University Law Review 81:1026

Mazzucato M (2017) Mission-oriented innovation policy: challenges and opportunities. UCL Institute for Innovation and Public Purpose Working Paper

McCarthy D, Wallace A (2018) Survey of GLAM open access policy and practice’, available at http://bit.ly/OpenGLAMsurvey

McKinsey & Company (2014) Offline and falling behind: barriers to internet adoption’, available at https://www.mckinsey.com/industries/technology-media-and-telecommunications/our-insights/offline-and-falling-behind-barriers-to-internet-adoption#

Merges R (2011) Justifying intellectual property. Harvard University Press

Moon S, Bermudez J, ‘t Hoen E (2012) Innovation and access to medicines for neglected populations: could a treaty address a broken pharmaceutical R&D system? PLoS Med 9(5)

Museums, Museum professionals and COVID-19 (ICOM 2020) https://icom.museum/wp-content/uploads/2020/05/Report-Museums-and-COVID-19.pdf

Museums around the World in the face of COVID-19 (UNESCO 2020) https://unesdoc.unesco.org/ark:/48223/pf0000373530.

Mysoor P (2020) Capturing the dynamism of fairness: a common law perspective. In: Daniel Gervais (ed), Fairness, morality and ordre public in intellectual property. Edward Elgar

NHS England concludes wide-ranging deal for cystic fibrosis drugs (2019) https://www.england.nhs.uk/2019/10/nhs-england-concludes-wide-ranging-deal-for-cystic-fibrosis-drugs/

Neuburger J (2020) Open COVID pledge rolled out to make patents and other IP available for COVID-19 response’ (New Media and Technology Law Blog) available at https://newmedialaw.proskauer.com/2020/04/21/open-covid-pledge-rolled-out-to-make-patents-and-other-ip-available-for-covid-19-response/#page=1

Okediji R (1999) Copyright and public welfare in global perspective. Indiana J Global Legal Stud 7:75

Okediji R (2003) The international relations of intellectual property: narratives of developing country participation in the global intellectual property system. Singap J Int Comp Law 7:315

Otero B (2020) Thinking Slow about IP in Times of Pandemic. IIC 51:555

Owoeye O, Owoeye O (2018) Intellectual property, access to medicines and universal health coverage through a health right lens. EIPR 40(1):49

Pekel J (2015) Making a big impact on a small budget - how the LSH museums shared their collection with the world’ (Europeana 2015) available at http://pro.europeana.eu/blogpost/making-a-big-impact-on-a-small-budget-how-the-lsh-museums-share

Pila J (2017) The Subject-matter of intellectual property. Oxford University Press

Pogge T, Rimmer M, Rubenstein K (2014) Incentives for global public health: patent law and access to essential medicines. Cambridge University Press

Price N et al (2020) Knowledge transfer for large-scale vaccine manufacturing. Science 369(6505):912

Public Statement: Fair use & emergency remote teaching & research (2020) https://docs.google.com/document/d/10baTITJbFRh7D6dHVVvfgiGP2zqaMvm0EHHZYf2cBRk/edit

Rose M (1996) Mothers and authors: Johnson V, Calvert and the New Children of Our Imaginations. Critical Inquiry 22:613

Schmidt A (2017) MKG collection online: the potential of open museum collections. HJK 7:25

Shadlen K, Guennif S, Guzman A, Lalitha N (eds) (2013) Intellectual property, pharmaceuticals and public health: access to drugs in developing countries Edward Elgar

Stinson A, Fauconnier S, Wyatt L (2018) Stepping beyond libraries: the changing orientation in flobal GLAM-Wiki. JLIS.it 9:16

Stothers C, Morgan A (2020) IP and the Supply of COVID-19-related drugs. JIPLP 15(8):590

Strandburg K (2018) Users, patents and innovation policy. In: Dreyfuss R, Pila J (eds) The Oxford handbook of intellectual property law. Oxford University Press

Suber P (2012) Open access. The MIT Press

Sunder M (2006) IP3. Stanford Law Rev 59:257

‘Survey on the impact of the COVID-19 situation on museums in Europe’ (Network of European Museums Organisations 2020) https://www.ne-mo.org/fileadmin/Dateien/public/NEMO_documents/NEMO_Corona_Survey_Results_6_4_20.pdf

‘t Hoen E (2020a) The € 7.4 Billion for Covid-19 product and vaccine development needs a few strings attached (Medicines Law and Policy) available at https://medicineslawandpolicy.org/2020/05/the-e-7-4-billion-for-covid-19-product-and-vaccine-development-needs-a-few-strings-attached/

‘t Hoen E (2020b) Covid-19 Intellectual property pool gaining support’ (Medicines Law & Policy) available at https://medicineslawandpolicy.org/2020/04/covid-19-intellectual-property-pool-gaining-support/.

‘t Hoen E (2020c) Covid-19 and the comeback of compulsory licensing’ (Medicines Law & Policy) available at https://medicineslawandpolicy.org/2020/03/covid-19-and-the-come-back-of-compulsory-licensing/

‘t Hoen E, Berger J, Calamy A, Moon S (2011) Driving a decade of change: HIV/AIDS, patents and access to medicines for all. J Int AIDS Soc 14

‘t Hoen E, Boulet P (2021) The European Commission says Covid-19 vaccines should be global public goods, but do their agreements with pharma reflect this?’ (Medicines, Law & Policy) available at https://medicineslawandpolicy.org/2021/01/the-european-commission-says-covid-19-vaccines-should-be-global-public-goods-but-do-their-agreements-with-pharma-reflect-this/

Tanner S (2004) Reproduction charging models & rights policy for digital images in American Art Museums: a mellon foundation funded study 40, available at http://msc.mellon.org/msc-files/Reproduction%20charging%20models%20and%20rights%20policy.pdf

Taylor J, Gibson LK (2017) Digitisation, digital interaction and social media: embedded barriers to democratic heritage. Int J Heritage Stud 23:408

Thambisetty S (2019) Improving access to patented medicines: are human rights getting in the way? IPQ 4:284

Trimble M (2020) COVID-19 and Transnational Issues in Copyright and Related Rights. IIC 51:407

Tushnet R (2017) Intellectual property as a public interest mechanism. In: Dreyfuss R, Pila J (eds) The Oxford handbook of intellectual property law. Oxford University Press

UCL Institute for Innovation and Public Purpose (2018) The people’s prescription: re-imagining health innovation to deliver public value. IIPP Policy Report, London (IIPP, Global Justice Now, Just Treatment, STOPAIDS), available at: https://www.ucl.ac.uk/bartlett/public-purpose/publications/2018/oct/peoples-prescription

UNAIDS (2020), ‘As pandemic deaths pass 1 million, COVID survivors from 37 countries write to pharmaceutical bosses to demand a People's Vaccine’ (UNAIDS) https://www.unaids.org/en/resources/presscentre/pressreleaseandstatementarchive/2020/september/20200929_covid-19-survivors-write-to-pharmaceutical-bosses-to-demand-a-peoples-vaccine

UNESCO Recommendation on Open Educational Resources (OER) (2019) http://portal.unesco.org/en/ev.php-URL_ID=49556&URL_DO=DO_TOPIC&URL_SECTION=201.html

Unitaid (2020) The Medicines Patent Pool and Unitaid Respond to Access Efforts for COVID-19 Treatments and Technologies’ (Unitaid) https://unitaid.org/news-blog/medicines-patent-pool-and-unitaid-respond-to-access-efforts-for-covid-19-treatments-and-technologies/#en

Valeonti F et al (2018) Reaping the benefits of digitisation: pilot study exploring revenue generation from digitised collections through technological innovation, available at https://www.scienceopen.com/document?vid=72172cf4-9b91-46cc-a494-bf95694a8610

Van Overwalle G (2015) Inventing inclusive patents: from old to new open innovation. In: Drahos P, Ghidini G, Ullrich H (eds) Kritika: essays on intellectual property. Edward Elgar

Van Overwalle G (2009) Gene patents and collaborative licensing models: patent pools, clearinghouses, open source models, and liability regimes. Cambridge University Press

van Zimmeren E, Van Overwalle G (2011) A paper tiger? Compulsory license regimes for public health in Europe. IIC 42:4

Vaver D (2013) Copyright defenses as user rights. J Copyright Soc USA 60(4):661

Verbeure B, van Zimmeren E, Matthijs G, Van Overwalle G (2006) Patent pools and diagnostic testing. Trends Biotechnol 24(3):115

Von Hippel E (2005) Democratizing innovation. The MIT Press

WHO Director-General’s opening remarks at the media briefing on COVID-19 (2021) https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-8-january-2021

WHO (2020) Commitments to share intellectual property, knowledge and data, https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/covid-19-technology-access-pool

WTO, Intellectual property and the public interest, https://www.wto.org/english/tratop_e/trips_e/trips_and_public_interest_e.htm

Wallace A, Deazley R (2016) Display At Your Own Risk, available at https://displayatyourownrisk.org/

Wallace A, Euler E (2020) Revisiting access to cultural heritage in the public domain: EU and international developments. IIC 51(7):823

Walsh K, Hawkins N (2020) Expanding the role of morality and public policy in European patent law. In: Torremans P (ed) Intellectual property and human rights. Wolters Kluwer

Wellcome (2020b) Coronavirus (COVID-19): sharing research data, https://wellcome.ac.uk/coronavirus-covid-19/open-data

Wellcome (2020a) Publishers Make Coronavirus (COVID-19) content freely available and reusable, https://wellcome.ac.uk/press-release/publishers-make-coronavirus-covid-19-content-freely-available-and-reusable